This is the first public court case in Switzerland by victims of this drug, still prescribed for epilepsy and migraine but now known to be dangerous for pregnant women.
Natascha Allenbach began testifying in a civil court in Geneva on Thursday, hoping for damages from French manufacturer Sanofi and the doctor who prescribed the drug. Her son Simon, now 19, has had serious medical problems since birth, including heart problems, malformation of the spine and neurological problems.
She only found out the cause in 2016. “The doctors knew in 2003. Why didn’t they tell us?” she said.
Court decision ahead
The court must now decide if the family has brought the case too late because of a ten-year limitation, or whether this ten-year deadline is too short for a handicap where the parents could not have known the cause earlier. If the family win, they will be able to sue Sanofi and the prescribing doctor for damages. But the hearings are likely to take several months, if not years.
In Switzerland, 39 children have been born with brain damage in connection to Depakine use, according to a report commissioned by the government, but specialists say the figure could be much higher.
In France, several thousand children are affected. For the first time this summer a court there recognised the responsibility of the French State and Sanofi, ordering them to pay compensation to families of seriously handicapped children.
Young undocumented migrants gain easier access to vocational training
This content was published on
Rejected asylum-seekers and young undocumented migrants in Switzerland will have easier access to basic vocational training from June 1.
Migration: Swiss government wants to shorten reunification period for families
This content was published on
Family members of people temporarily admitted to Switzerland should in future be able to join them after two years instead of three.
This content was published on
2023 was a record year for the Rhaetian Railway in several respects. Never before has the narrow-gauge railway in Graubünden, eastern Switzerland, transported so many passengers and cars.
Swiss CFOs much more optimistic despite global uncertainty
This content was published on
The main concerns of business leaders in Switzerland are geopolitical uncertainty and the important trading partners Germany and China.
Record organ donation in Switzerland despite high rejection rates
This content was published on
More organ donations were recorded in Switzerland in 2023 than ever before. This was despite a high rejection rate of 58% by surviving relatives.
This content was published on
Seven years after the death of record-breaking Swiss mountain climber Ueli Steck, his estate is going to the Alpine Museum of Switzerland in Bern.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss parents take French drugmaker to court
This content was published on
They accuse their neurologists and the French drug manufacturer Sanofi, which produces Depakine, of failing to warn them about the risks to the fetus, according to reports published on Le Matin Dimanche and SonntagsZeitung. Depakine is still widely used today to treat epilepsy and migraines. Scientists have established that the sodium valproate contained in the…
Swiss pharma giants swallow up start-ups in push for next big gene therapy
This content was published on
Swiss drug makers are increasingly relying on buying science rather than doing it themselves in the search for the next big medical breakthrough.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.